<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23271" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hypomagnesemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gragossian</surname>
            <given-names>Alin</given-names>
          </name>
          <aff>Drexel University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bashir</surname>
            <given-names>Khalid</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhutta</surname>
            <given-names>Beenish S.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Friede</surname>
            <given-names>Rotem</given-names>
          </name>
          <aff>Mercy Catholic Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alin Gragossian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Khalid Bashir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Beenish Bhutta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rotem Friede declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>11</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23271.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Magnesium, a crucial electrolyte,&#x000a0;is a key component of&#x000a0;various physiological processes within the human body, influencing cellular function, nerve conduction, and overall well-being.&#x000a0;Despite magnesium's&#x000a0;vital&#x000a0;role in physiological processes, clinicians may overlook the criticality of maintaining normal serum levels of 1.46 to 2.68 mg/dL.&#x000a0;Hypomagnesemia, characterized by a serum magnesium level below 1.46 mg/dL, poses various challenges and complications, demanding a comprehensive understanding of its evaluation, treatment, and potential consequences.</p>
        <p>The course begins with an exploration of the etiology of hypomagnesemia, examining its association with chronic diseases, alcohol use disorder, gastrointestinal and renal losses, and other contributing factors. Learners will gain insights into the diverse clinical manifestations of hypomagnesemia, ranging from mild tremors and generalized weakness to severe complications such as cardiac ischemia and, in extreme cases, death. The core of the course focuses on evaluating and treating hypomagnesemia, emphasizing evidence-based approaches and the latest advancements in medical practice. Participants will explore diagnostic methods, understand how to assess magnesium levels and identify contributing factors accurately. A key highlight of this activity is the emphasis on the interprofessional team approach to managing hypomagnesemia for optimizing patient outcomes.&#x000a0;</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between various etiological factors contributing to hypomagnesemia, such as chronic diseases and alcohol use disorder, to inform tailored treatment approaches.</p></list-item><list-item><p>Implement evidence-based treatment modalities for hypomagnesemia, including oral and intravenous interventions, considering individual patient's severity and unique needs.</p></list-item><list-item><p>Identify the diverse symptoms and clinical manifestations associated with hypomagnesemia for prompt and accurate diagnosis.</p></list-item><list-item><p>Improve interprofessional collaboration, acknowledging the necessity of teamwork for holistic hypomagnesemia management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23271&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23271">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23271.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Magnesium is a vital electrolyte that plays a crucial role in many biochemical reactions in the human body, affecting cellular function, nerve conduction, and other needs. Normal serum magnesium levels are between 1.46 and 2.68 mg/dL. Hypomagnesemia is an electrolyte disturbance caused by a low serum magnesium level of less than 1.46 mg/dL in the blood. However, this condition is typically asymptomatic until serum magnesium concentration is less than 1.2 mg/dL (0.5 mmol/L).<xref ref-type="bibr" rid="article-23271.r1">[1]</xref></p>
        <p>Chronic disease, alcohol use disorder, gastrointestinal loss, renal loss, and other conditions can be attributed to hypomagnesemia. Signs and symptoms of hypomagnesemia include mild tremors and generalized weakness to cardiac ischemia and death.<xref ref-type="bibr" rid="article-23271.r2">[2]</xref><xref ref-type="bibr" rid="article-23271.r3">[3]</xref><xref ref-type="bibr" rid="article-23271.r4">[4]</xref></p>
      </sec>
      <sec id="article-23271.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hypomagnesemia can be secondary to decreased intake.<xref ref-type="bibr" rid="article-23271.r5">[5]</xref>&#x000a0;This is the case as seen in the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Starvation</p>
          </list-item>
          <list-item>
            <p>Alcohol use disorder (with a reported prevalence of 30%)<xref ref-type="bibr" rid="article-23271.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Anorexia nervosa</p>
          </list-item>
          <list-item>
            <p>Terminal cancer</p>
          </list-item>
          <list-item>
            <p>Critically ill patients who are receiving total parenteral nutrition</p>
          </list-item>
        </list>
        <p>Hypomagnesemia can also be secondary to the following medications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Loop and thiazide diuretics</p>
          </list-item>
          <list-item>
            <p>Proton pump inhibitors</p>
          </list-item>
          <list-item>
            <p>Aminoglycoside antibiotics</p>
          </list-item>
          <list-item>
            <p>Amphotericin B</p>
          </list-item>
          <list-item>
            <p>Pentamidine</p>
          </list-item>
          <list-item>
            <p>Digitalis</p>
          </list-item>
          <list-item>
            <p>Chemotherapeutic drugs, such as cisplatin, cyclosporine</p>
          </list-item>
          <list-item>
            <p>Antibodies that bind to epidermal growth factor (EGF) receptors (cetuximab, matuzumab, panitumumab)</p>
          </list-item>
          <list-item>
            <p>Laxative abuse&#x000a0;<xref ref-type="bibr" rid="article-23271.r1">[1]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>This condition can also result from redistribution from the extracellular to the intracellular compartment.<xref ref-type="bibr" rid="article-23271.r7">[7]</xref>&#x000a0;The following are in this category:</p>
        <list list-type="bullet">
          <list-item>
            <p>Treatment of diabetic ketoacidosis by insulin</p>
          </list-item>
          <list-item>
            <p>Refeeding syndrome</p>
          </list-item>
          <list-item>
            <p>Correction of metabolic acidosis</p>
          </list-item>
          <list-item>
            <p>Acute pancreatitis</p>
          </list-item>
          <list-item>
            <p>Ethanol withdrawal syndrome</p>
          </list-item>
        </list>
        <p>Lastly, hypomagnesemia can be induced by gastrointestinal and renal losses.<xref ref-type="bibr" rid="article-23271.r1">[1]</xref>&#x000a0;This includes but is not limited to the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute diarrhea</p>
          </list-item>
          <list-item>
            <p>Chronic diarrhea (Crohn disease, ulcerative colitis)</p>
          </list-item>
          <list-item>
            <p>Hungry bone syndrome (an increased magnesium uptake by renewing bone following parathyroidectomy or thyroidectomy, causing a decrease in serum magnesium)</p>
          </list-item>
          <list-item>
            <p>Acute pancreatitis</p>
          </list-item>
          <list-item>
            <p>Gastric bypass surgery</p>
          </list-item>
          <list-item>
            <p>Genetic disorders</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Gitelman syndrome</p>
              </list-item>
              <list-item>
                <p>Bartter syndrome</p>
              </list-item>
              <list-item>
                <p>Familial hypomagnesemia with hypercalciuria and nephrocalcinosis</p>
              </list-item>
              <list-item>
                <p>Renal malformations and early-onset diabetes mellitus caused by HNF1-beta mutation</p>
              </list-item>
              <list-item>
                <p>Autosomal recessive isolated hypomagnesemia caused by EGF mutation</p>
              </list-item>
              <list-item>
                <p>Autosomal dominant isolated hypomagnesemia caused by Na-K-ATPase gamma subunit, Kv1.1, and cyclin M2 mutations</p>
              </list-item>
              <list-item>
                <p>Intestinal hypomagnesemia with secondary hypocalcemia</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Acquired tubular dysfunction</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Post-kidney transplant</p>
              </list-item>
              <list-item>
                <p>Recovery from acute tubular necrosis</p>
              </list-item>
              <list-item>
                <p>Postobstructive diuresis</p>
              </list-item>
            </list>
          </list-item>
        </list>
      </sec>
      <sec id="article-23271.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The risk of hypomagnesemia depends on multiple characteristics in various healthcare settings.&#x000a0;The reported prevalence in the general population is 2.5% to 15%. In hospitalized patients, it ranges from 12% to 20%.<xref ref-type="bibr" rid="article-23271.r8">[8]</xref><xref ref-type="bibr" rid="article-23271.r9">[9]</xref>&#x000a0;The prevalence is even higher in critically ill patients, estimated at 65% in a study.<xref ref-type="bibr" rid="article-23271.r1">[1]</xref>&#x000a0;</p>
        <p>In&#x000a0;a study of 100 critically ill children (mean age 4.9 years) admitted to a pediatric intensive care unit in India, the prevalence was about 55%. A study revealed a 30% prevalence in patients with chronic alcohol use disorder.<xref ref-type="bibr" rid="article-23271.r10">[10]</xref>&#x000a0; No recent studies have identified which age groups are at higher risk of hypomagnesemia.</p>
      </sec>
      <sec id="article-23271.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>An adult human body contains 25 g or 1000 mmol of magnesium.<xref ref-type="bibr" rid="article-23271.r11">[11]</xref>&#x000a0;Magnesium is the second most abundant intracellular cation after potassium and a cofactor in many biochemical reactions. About 99% of magnesium is in bone (60%) and soft tissues (40%).<xref ref-type="bibr" rid="article-23271.r11">[11]</xref></p>
        <p>Magnesium directly affects various other electrolytes, including sodium, calcium, and potassium. As described above, low magnesium levels can occur secondary to renal and gastrointestinal losses.<xref ref-type="bibr" rid="article-23271.r12">[12]</xref><xref ref-type="bibr" rid="article-23271.r13">[13]</xref></p>
        <p>Magnesium homeostasis involves the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>The kidney (primarily through the proximal tubule, the thick ascending loop of Henle, and the distal tubule)</p>
          </list-item>
          <list-item>
            <p>Small bowel (primarily through the jejunum and ileum)</p>
          </list-item>
          <list-item>
            <p>Bone</p>
          </list-item>
        </list>
        <p>Hypomagnesemia occurs when a drug or a disease condition alters magnesium homeostasis.</p>
        <p>Magnesium is essential for many functions, including the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cofactor activity for more than 300 enzymatic reactions</p>
          </list-item>
          <list-item>
            <p>Platelet function (clotting and thrombus formation)</p>
          </list-item>
          <list-item>
            <p>Maintenance of vascular tone</p>
          </list-item>
          <list-item>
            <p>Platelet-activated thrombosis</p>
          </list-item>
          <list-item>
            <p>Muscle contraction and relaxation</p>
          </list-item>
          <list-item>
            <p>Insulin regulation</p>
          </list-item>
          <list-item>
            <p>Neurotransmission</p>
          </list-item>
          <list-item>
            <p>Cardiac conduction</p>
          </list-item>
          <list-item>
            <p>Bone formation</p>
          </list-item>
        </list>
        <p>
<bold>Acquired Hypomagnesemia</bold>
</p>
        <p>Magnesium deficiency also can cause hypocalcemia, as the 2 are interrelated. Decreased magnesium causes impaired magnesium-dependent adenyl cyclase generation of cyclic adenosine monophosphate (cAMP), decreasing parathyroid hormone (PTH) release, and decreasing calcium levels&#x02014;as PTH regulates calcium levels.</p>
        <p>Magnesium also affects the electrical activity of the myocardium and vascular tone, which is why patients with hypomagnesemia are at risk for cardiac arrhythmias. In addition, when magnesium is low, there is inhibition of renal outer medullary potassium channels, leading to increased urinary excretion and depletion of intracellular potassium levels; this reduces the threshold required for generating an action potential in the cardiac myocyte. Moreover, reduced intracellular potassium levels also prolong the time to repolarize the cell membrane, increasing the risk of arrhythmias.</p>
        <p>
<bold>Inherited Hypomagnesemias</bold>
</p>
        <p><bold>Gitelman syndrome:</bold>&#x000a0;This condition is caused by recessive mutations in the gene that codes for the thiazide-sensitive sodium chloride cotransporter (<italic toggle="yes">SLC12A3</italic>) in the distal convoluted tubule (DCT). Transcellular reabsorption of magnesium in the DCT is impaired, leading to increased calcium reabsorption, and the subsequent hypocalciuria and fluid loss tend to lower blood pressure. In addition, fluid loss activates the renin-angiotensin-aldosterone system, and increased aldosterone causes increased potassium secretion in exchange for sodium and subsequent hypokalemia.<xref ref-type="bibr" rid="article-23271.r14">[14]</xref></p>
        <p><bold>Hypercalciuric hypomagnesemias:&#x000a0;</bold>Mutations affect the reabsorption of magnesium and calcium ions in the thick ascending limb of Henle (TAL), leading to hypercalciuric hypomagnesemia that ultimately results in nephrocalcinosis or chronic kidney disease.<xref ref-type="bibr" rid="article-23271.r14">[14]</xref></p>
        <p><bold>EAST (SeSAME) syndrome:</bold>&#x000a0;This condition is caused by loss-of-function mutations in the gene encoding the potassium channel,&#x000a0;<italic toggle="yes">KCNJ10</italic>&#x000a0;(Kir4.1), on the basolateral membrane of the DCT. It results in hypomagnesemia, salt wasting, metabolic alkalosis, and hypokalemia. The mechanism, however, is poorly understood.<xref ref-type="bibr" rid="article-23271.r14">[14]</xref><xref ref-type="bibr" rid="article-23271.r15">[15]</xref></p>
      </sec>
      <sec id="article-23271.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with symptomatic magnesium depletion can present in many ways. The major clinical manifestations include neuromuscular and cardiovascular manifestations and other electrolyte abnormalities.</p>
        <p>Early presentation of hypomagnesemia includes nausea, vomiting, loss of appetite, fatigue, and weakness.<xref ref-type="bibr" rid="article-23271.r5">[5]</xref>&#x000a0;Patients may complain of dysphagia, muscular weakness, and other symptoms, as described below.<xref ref-type="bibr" rid="article-23271.r7">[7]</xref></p>
        <p>
<bold>Neuromuscular Manifestations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Neuromuscular hyperexcitability (often the first clinical manifestation)<xref ref-type="bibr" rid="article-23271.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Tremors</p>
          </list-item>
          <list-item>
            <p>Tetany, including positive Trousseau and Chvostek signs, muscle spasms, and muscle cramps. Tetany may occur in the absence of hypocalcemia and alkalosis and is presumably due to lowering the threshold for nerve stimulation.<xref ref-type="bibr" rid="article-23271.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Choreoathetosis&#x000a0;<xref ref-type="bibr" rid="article-23271.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Seizures</p>
          </list-item>
          <list-item>
            <p>Vertical nystagmus</p>
          </list-item>
          <list-item>
            <p>Apathy</p>
          </list-item>
          <list-item>
            <p>Delirium</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Agitation</p>
          </list-item>
          <list-item>
            <p>Psychosis</p>
          </list-item>
          <list-item>
            <p>Delirium</p>
          </list-item>
          <list-item>
            <p>Coma</p>
          </list-item>
        </list>
        <p>
<bold>Cardiovascular Manifestations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Electrocardiogram changes, including widening of the QRS complex, peaked T waves (with mild to moderate deficiency), prolongation of the PR interval, and diminution of the T wave (with severe deficiency)<xref ref-type="bibr" rid="article-23271.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Atrial and ventricular premature systoles</p>
          </list-item>
          <list-item>
            <p>Atrial fibrillation</p>
          </list-item>
          <list-item>
            <p>Ventricular arrhythmias, including torsades de pointes</p>
          </list-item>
          <list-item>
            <p>Cardiac ischemia</p>
          </list-item>
          <list-item>
            <p>Increased risk of digoxin toxicity by inhibiting Na-K-ATPase and depleting intracellular potassium&#x000a0;<xref ref-type="bibr" rid="article-23271.r19">[19]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Other Electrolyte and Hormone Abnormalities</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypocalcemia</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Symptoms typically occur when magnesium levels are below 1 mEq/L (0.5 mmol/L or 1.2 mg/dL).</p>
              </list-item>
              <list-item>
                <p>Milder hypomagnesemia (between 1.1 and 1.3 mEq/L) lowers the plasma calcium concentration only slightly (0.2 mg/dL or 0.05 mmol/L)<xref ref-type="bibr" rid="article-23271.r20">[20]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Hypoparathyroidism</p>
          </list-item>
          <list-item>
            <p>Hypokalemia (about 60% of cases)</p>
          </list-item>
        </list>
        <p>A case report describes symptoms of cerebellar ataxia, generalized convulsions, intermittent downbeat nystagmus, and supraventricular tachycardia in a 59-year-old man with severe hypomagnesemia.<xref ref-type="bibr" rid="article-23271.r21">[21]</xref></p>
      </sec>
      <sec id="article-23271.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>&#x000a0;Check the following in a patient suspected of having hypomagnesemia:</p>
        <list list-type="bullet">
          <list-item>
            <p>Serum magnesium, phosphate, and calcium level</p>
          </list-item>
          <list-item>
            <p>A basic metabolic panel, including serum creatinine/kidney function and glucose levels</p>
          </list-item>
          <list-item>
            <p>Electrocardiogram to rule out arrhythmias</p>
          </list-item>
        </list>
        <p>There is currently no clinically available "ionized" magnesium test. When in doubt, distinguishing between gastrointestinal and renal losses can be achieved by measuring the 24-hour urinary magnesium excretion. In addition, one can calculate the fractional excretion of magnesium (on a random urine specimen) with the following formula, where U and P refer to the urine and plasma concentrations of magnesium (Mg) and creatinine (Cr).</p>
        <list list-type="bullet">
          <list-item>
            <p>FEMg = [(UMg x PCr) / (PMg x UCr x 0.7)] x 100</p>
          </list-item>
        </list>
        <p>After confirming hypomagnesemia, typically obtain the etiology from the patient's history, which may include the mentioned causes.</p>
        <p>During the examination, look for vertical nystagmus and tetany. Check for the following signs:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chvostek sign: Tapping on facial nerve leads to twitching of facial muscles</p>
          </list-item>
          <list-item>
            <p>Trousseau sign: Carpopedal spasm induced by inflated blood pressure cuff</p>
          </list-item>
        </list>
        <p>If the fractional excretion of magnesium is above 2% in someone with normal renal function, the hypomagnesemia is likely secondary to renal magnesium wasting from drugs such as diuretics, aminoglycosides, or cisplatin.</p>
        <p>Consider genetic testing if there is a positive family history, unexplained hypomagnesemia, or if the discovery of the condition is early in infancy (see <bold>Table 1.</bold> Various Genetic Disorders That Cause Hypomagnesemia).</p>
        <table-wrap id="article-23271.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1. Various Genetic Disorders That Cause Hypomagnesemia&#x000a0;[22]</title>
          </caption>
          <table style="height: 127px; width: 661px;" border="1" cellspacing="0" cellpadding="4">
            <tbody>
              <tr style="height: 26px;">
                <td style="width: 277px; height: 26px;" rowspan="1" colspan="1">
<bold>Disorder</bold>
</td>
                <td style="width: 277px; height: 26px;" rowspan="1" colspan="1">
<p><bold>Gene Mutation</bold></p>
</td>
                <td style="width: 239.938px; height: 26px;" rowspan="1" colspan="1">
<bold>Clinical Symptoms</bold>
</td>
              </tr>
              <tr style="height: 26px;">
                <td style="width: 277px; height: 26px;" rowspan="1" colspan="1">Gitelman syndrome</td>
                <td style="width: 277px; height: 26px;" rowspan="1" colspan="1">
<p><italic toggle="yes">SLC12A3</italic></p>
</td>
                <td style="width: 239.938px; height: 26px;" rowspan="1" colspan="1">Cardiac arrhythmias and prolonged QT intervals on an electrocardiogram</td>
              </tr>
              <tr style="height: 26px;">
                <td style="width: 277px; height: 26px;" rowspan="1" colspan="1">Bartter syndrome type 4</td>
                <td style="width: 277px; height: 26px;" rowspan="1" colspan="1">
<italic toggle="yes">BSND</italic>
</td>
                <td style="width: 239.938px; height: 26px;" rowspan="1" colspan="1">Early renal failure, prenatal complications</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 277px; height: 13px;" rowspan="1" colspan="1">EAST syndrome</td>
                <td style="width: 277px; height: 13px;" rowspan="1" colspan="1">
<italic toggle="yes">KCNJ10</italic>
</td>
                <td style="width: 239.938px; height: 13px;" rowspan="1" colspan="1">Seizures, sensorineural deafness</td>
              </tr>
              <tr style="height: 13.5px;">
                <td style="width: 277px; height: 13.5px;" rowspan="1" colspan="1">Hypomagnesemia with secondary hypomagnesemia</td>
                <td style="width: 277px; height: 13.5px;" rowspan="1" colspan="1">
<italic toggle="yes">CNNM2</italic>
</td>
                <td style="width: 239.938px; height: 13.5px;" rowspan="1" colspan="1">Intellectual disability</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-23271.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treating patients with hypomagnesemia is based on the state of kidney function, the severity of symptoms, and hemodynamic stability. If a patient is hemodynamically unstable in an acute hospital setting, 1 to 2 g of magnesium sulfate can be given in about 15 minutes. For symptomatic, severe hypomagnesemia in a stable patient, 1 to 2 g of magnesium sulfate can be given over 1 hour. Non-emergent repletion of the adult patient is generally 4 to 8 g of magnesium sulfate given slowly over 12 to 24 hours. In pediatric patients, the dose is 25 to 50 mg/kg (with a maximum of 2 g).<xref ref-type="bibr" rid="article-23271.r11">[11]</xref><xref ref-type="bibr" rid="article-23271.r23">[23]</xref></p>
        <p>Try sustained-release oral replacement first in an asymptomatic patient who is not hospitalized and can tolerate medications by mouth.</p>
        <p>Asymptomatic patients can benefit from oral sustained-release magnesium preparations (magnesium chloride containing 64-71.5 mg or magnesium L-lactate containing 84 mg elemental magnesium).</p>
        <p>After repletion, recheck serum electrolyte levels (whether in an inpatient or outpatient setting) to ensure effective treatment. Although serum magnesium levels rise quickly with treatment, intracellular magnesium takes longer to replenish. Thus, patients with normal renal function should try to continue magnesium repletion for 2 days after the level normalizes.</p>
        <p>Use caution in repleting magnesium in patients with abnormal kidney function (defined as creatinine clearance less than 30 mL/min/1.73 m<sup>2</sup>). These patients are at risk of hypermagnesemia. Study findings recommend reducing the magnesium dose by 50% and closely monitoring magnesium levels in these patients.</p>
        <p>Selected food sources (see <bold>Table 2.</bold> Food Sources of Magnesium) should also be considered while giving supplements to patients with adequate intake.</p>
        <table-wrap id="article-23271.table1" position="float" orientation="portrait">
          <caption>
            <title>Table 2. Food Sources of Magnesium&#x000a0;[24]</title>
          </caption>
          <table border="1" cellspacing="0" cellpadding="4">
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<bold>Food</bold>
</td>
                <td rowspan="1" colspan="1">
<bold>Magnesium per Serving</bold>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Halibut, cooked, 3 oz</td>
                <td rowspan="1" colspan="1">90 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Almonds, dry roasted, 1 oz</td>
                <td rowspan="1" colspan="1">80 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Cashews, dry roasted, 1 oz</td>
                <td rowspan="1" colspan="1">75 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Peanuts, dry roasted, 1 oz</td>
                <td rowspan="1" colspan="1">50 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Spinach, frozen or cooked, one-half&#x000a0;cup</td>
                <td rowspan="1" colspan="1">75 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Wheat bran, crude, 2 tablespoons</td>
                <td rowspan="1" colspan="1">45 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Oatmeal, instant, fortified, prepared with water, 1 cup</td>
                <td rowspan="1" colspan="1">55 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Potato, baked with skin, 1 medium</td>
                <td rowspan="1" colspan="1">50 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Cereal, shredded wheat, 2 rectangular biscuits</td>
                <td rowspan="1" colspan="1">55 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Rice, brown, long-grained, cooked, one-half cup</td>
                <td rowspan="1" colspan="1">40 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Yogurt, plain, skim milk, 8 fl oz</td>
                <td rowspan="1" colspan="1">45 mg</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Bran flakes, three-fourths cup</td>
                <td rowspan="1" colspan="1">40 mg</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The underlying cause of persistent hypomagnesemia should be addressed and treated. For example, if patients consistently have low electrolyte levels due to renal losses, they may benefit from amiloride, a potassium- and magnesium-sparing diuretic.</p>
        <p>In patients with concurrent hypocalcemia, replace calcium before initiating magnesium replacement to avoid increased urinary excretion of calcium caused by sulfate from magnesium sulfate, making complex with ionized calcium.<xref ref-type="bibr" rid="article-23271.r25">[25]</xref></p>
        <p>Potassium-sparing diuretics (amiloride or triamterene) should be considered in patients with diuretic-induced hypomagnesemia (when diuretic therapy cannot be discontinued) or chronic renal magnesium wasting.<xref ref-type="bibr" rid="article-23271.r1">[1]</xref></p>
      </sec>
      <sec id="article-23271.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Always check for other electrolyte abnormalities when suspecting or treating hypomagnesemia. Low magnesium levels can, in turn, cause low potassium and calcium levels. Furthermore, many additional electrolyte and hormonal abnormalities can present with similar symptoms. Distinguish hypomagnesemia from the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoparathyroidism (genetic and idiopathic)</p>
          </list-item>
          <list-item>
            <p>Acrodysostosis</p>
          </list-item>
          <list-item>
            <p>Pseudohypoparathyroidism&#x000a0;<xref ref-type="bibr" rid="article-23271.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Blomstrand chondrodysplasia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23271.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Hypomagnesemia prognosis depends on the underlying cause of hypomagnesemia. Patients with hypomagnesemia from an identifiable cause have a good prognosis for complete recovery. However, in critically ill patients, this condition is associated with increased length of ICU stay, mortality, and need for mechanical ventilation.<xref ref-type="bibr" rid="article-23271.r27">[27]</xref></p>
      </sec>
      <sec id="article-23271.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Treating hypomagnesemia is essential. Dangerously low magnesium levels can potentially cause fatal cardiac arrhythmias, such as torsades de pointes (polymorphous ventricular tachycardia with marked QT prolongation). Moreover, hypomagnesemia in patients with acute myocardial infarction puts them at a higher risk of ventricular arrhythmias within the first 24 hours. Furthermore, hypomagnesemia may also cause chondrocalcinosis.<xref ref-type="bibr" rid="article-23271.r14">[14]</xref></p>
      </sec>
      <sec id="article-23271.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consider consulting a nephrologist if an inherited tubular disorder is suspected or in a patient whose magnesium levels are difficult to regulate. Consult a cardiologist if a patient has a cardiac arrhythmia from magnesium deficiency, and monitor the patient closely on a telemetry floor or critical care unit.</p>
      </sec>
      <sec id="article-23271.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with recurrent hypomagnesemia should be encouraged to eat a modest amount of magnesium-containing foods, as described above. Advise patients to seek help from specialists for their chronic medical illnesses that may be causing hypomagnesemia. Moreover, patients with chronic alcohol use should restrict alcohol as it is associated with hypomagnesemia.</p>
      </sec>
      <sec id="article-23271.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Magnesium deficiency is commonly encountered in clinical practice. The key is to find the primary cause. Asymptomatic patients can be managed with supplements prescribed as outpatients. Symptomatic patients need admission and parenteral magnesium. The prognosis for most patients with a reversible cause is excellent.</p>
        <p>Clinicians, nurses, and pharmacists must coordinate care, working as an interprofessional team to resolve magnesium deficiency rapidly. Clinicians and nurses will obtain lab values to determine if the condition exists; searching for the underlying cause is necessary.</p>
        <p>Consult pharmacists to help determine if medications are the underlying culprit. The clinicians&#x000a0;will determine the course of action for correcting hypomagnesemia and&#x000a0;may consult with the pharmacist on dosing. A dietician may also be consulted to ensure the patient's dietary magnesium intake coordinates with the interventions taken and can prevent future episodes.</p>
        <p>Patient care often involves educating the patient and family and an interprofessional team approach from the health practitioners. This team paradigm will yield the best management and patient outcomes.</p>
      </sec>
      <sec id="article-23271.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23271&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23271">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/hypomagnesemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23271">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23271/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23271">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23271.s16">
        <title>References</title>
        <ref id="article-23271.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayuk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gittoes</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>How should hypomagnesaemia be investigated and treated?</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>75</volume>
            <issue>6</issue>
            <fpage>743</fpage>
            <page-range>743-6</page-range>
            <pub-id pub-id-type="pmid">21569071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andreozzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cuminetti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karmali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kamgang</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Electrolyte Disorders as Triggers for Takotsubo Cardiomyopathy.</article-title>
            <source>Eur J Case Rep Intern Med</source>
            <year>2018</year>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>000760</fpage>
            <pub-id pub-id-type="pmid">30756021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurstjens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bouras</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Overmars-Bos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kebieche</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bindels</surname>
                <given-names>RJM</given-names>
              </name>
              <name>
                <surname>Hoenderop</surname>
                <given-names>JGJ</given-names>
              </name>
              <name>
                <surname>de Baaij</surname>
                <given-names>JHF</given-names>
              </name>
            </person-group>
            <article-title>Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice.</article-title>
            <source>Sci Rep</source>
            <year>2019</year>
            <month>Feb</month>
            <day>11</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>1770</fpage>
            <pub-id pub-id-type="pmid">30742025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brophy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sheahan</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Perioperative magnesium levels in total thyroidectomy and relationship to hypocalcemia.</article-title>
            <source>Head Neck</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>1713</fpage>
            <page-range>1713-1718</page-range>
            <pub-id pub-id-type="pmid">30628752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jahnen-Dechent</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ketteler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Magnesium basics.</article-title>
            <source>Clin Kidney J</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>Suppl 1</issue>
            <fpage>i3</fpage>
            <page-range>i3-i14</page-range>
            <pub-id pub-id-type="pmid">26069819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koulouridis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Alfayez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tighiouart</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Madias</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Paulus</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Jaber</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>730</fpage>
            <page-range>730-7</page-range>
            <pub-id pub-id-type="pmid">23664547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moe</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Disorders involving calcium, phosphorus, and magnesium.</article-title>
            <source>Prim Care</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>215</fpage>
            <page-range>215-37, v-vi</page-range>
            <pub-id pub-id-type="pmid">18486714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agus</surname>
                <given-names>ZS</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms and causes of hypomagnesemia.</article-title>
            <source>Curr Opin Nephrol Hypertens</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>301</fpage>
            <page-range>301-7</page-range>
            <pub-id pub-id-type="pmid">27219040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheungpasitporn</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Thongprayoon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Dysmagnesemia in Hospitalized Patients: Prevalence and Prognostic Importance.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>90</volume>
            <issue>8</issue>
            <fpage>1001</fpage>
            <page-range>1001-10</page-range>
            <pub-id pub-id-type="pmid">26250725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Marchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cecchin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Basile</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bertotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nardini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bartoli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Renal tubular dysfunction in chronic alcohol abuse--effects of abstinence.</article-title>
            <source>N Engl J Med</source>
            <year>1993</year>
            <month>Dec</month>
            <day>23</day>
            <volume>329</volume>
            <issue>26</issue>
            <fpage>1927</fpage>
            <page-range>1927-34</page-range>
            <pub-id pub-id-type="pmid">8247056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Bruserud</surname>
                <given-names>&#x000d8;</given-names>
              </name>
            </person-group>
            <article-title>Hypomagnesemia in critically ill patients.</article-title>
            <source>J Intensive Care</source>
            <year>2018</year>
            <volume>6</volume>
            <fpage>21</fpage>
            <pub-id pub-id-type="pmid">29610664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis and treatment of electrolyte problems post transplant.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-218</page-range>
            <pub-id pub-id-type="pmid">30585865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fulchiero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Seo-Mayer</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Bartter Syndrome and Gitelman Syndrome.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-134</page-range>
            <pub-id pub-id-type="pmid">30454738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viering</surname>
                <given-names>DHHM</given-names>
              </name>
              <name>
                <surname>de Baaij</surname>
                <given-names>JHF</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kleta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bockenhauer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Genetic causes of hypomagnesemia, a clinical overview.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>1123</fpage>
            <page-range>1123-1135</page-range>
            <pub-id pub-id-type="pmid">27234911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>XT</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Scholl</surname>
                <given-names>UI</given-names>
              </name>
              <name>
                <surname>Giebisch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lifton</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1).</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2014</year>
            <month>Aug</month>
            <day>12</day>
            <volume>111</volume>
            <issue>32</issue>
            <fpage>11864</fpage>
            <page-range>11864-9</page-range>
            <pub-id pub-id-type="pmid">25071208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tong</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Rude</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Magnesium deficiency in critical illness.</article-title>
            <source>J Intensive Care Med</source>
            <year>2005</year>
            <season>Jan-Feb</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-17</page-range>
            <pub-id pub-id-type="pmid">15665255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kitzes</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinical clues to magnesium deficiency.</article-title>
            <source>Isr J Med Sci</source>
            <year>1987</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>12</issue>
            <fpage>1238</fpage>
            <page-range>1238-41</page-range>
            <pub-id pub-id-type="pmid">3440747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>An</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarction.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e98971</fpage>
            <pub-id pub-id-type="pmid">24901943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seller</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Cangiano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Mendelssohn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brest</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Swartz</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Digitalis toxicity and hypomagnesemia.</article-title>
            <source>Am Heart J</source>
            <year>1970</year>
            <month>Jan</month>
            <volume>79</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-68</page-range>
            <pub-id pub-id-type="pmid">5410283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fatemi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ryzen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Flores</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Endres</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Rude</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>73</volume>
            <issue>5</issue>
            <fpage>1067</fpage>
            <page-range>1067-72</page-range>
            <pub-id pub-id-type="pmid">1939521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sedehizadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Keogh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wills</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Reversible hypomagnesaemia-induced subacute cerebellar syndrome.</article-title>
            <source>Biol Trace Elem Res</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>142</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-9</page-range>
            <pub-id pub-id-type="pmid">20607440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Baaij</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Dorresteijn</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hennekam</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Kamsteeg</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dahan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van den Dorpel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bindels</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hoenderop</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Knoers</surname>
                <given-names>NV</given-names>
              </name>
            </person-group>
            <article-title>Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>952</fpage>
            <page-range>952-7</page-range>
            <pub-id pub-id-type="pmid">25765846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greco</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Endocrine causes of calcium disorders.</article-title>
            <source>Top Companion Anim Med</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>150</fpage>
            <page-range>150-5</page-range>
            <pub-id pub-id-type="pmid">23415381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerrera</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Volpe</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic uses of magnesium.</article-title>
            <source>Am Fam Physician</source>
            <year>2009</year>
            <month>Jul</month>
            <day>15</day>
            <volume>80</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-62</page-range>
            <pub-id pub-id-type="pmid">19621856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Radin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McCurdy</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Calcium, magnesium, and phosphate abnormalities in the emergency department.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2014</year>
            <month>May</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>349</fpage>
            <page-range>349-66</page-range>
            <pub-id pub-id-type="pmid">24766937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>An update on the clinical and molecular characteristics of pseudohypoparathyroidism.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>443</fpage>
            <page-range>443-51</page-range>
            <pub-id pub-id-type="pmid">23076042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23271.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Upala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jaruvongvanich</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wijarnpreecha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sanguankeo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hypomagnesemia and mortality in patients admitted to intensive care unit: a systematic review and meta-analysis.</article-title>
            <source>QJM</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>109</volume>
            <issue>7</issue>
            <fpage>453</fpage>
            <page-range>453-459</page-range>
            <pub-id pub-id-type="pmid">27016536</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
